Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q2 | Jun 30, 2024 | Apis Deep Value Fund | 3.1% | - | 4506.T, 8069.T, AAPL, AMZN, DPZ, MCD, META, MSFT, NFLX, OLED, WMT | Asia, defense, Electrification, Long/Short, small caps, technology, value | Goldman Sachs report highlights advantages of SMID-cap investing including thousands of stock-picking opportunities versus concentrated large-cap indices, significant inefficiencies with many companies having no analyst coverage, and less competitive space with only 3% of equity long/short funds focusing on SMID-cap. Current valuation extremes show profitable Russell 2000 companies trading at 15x with 35% growth versus S&P at 23x with 14% growth. | 4506.T 8069.TW 1405.HK |
View |
| 2026 Q1 | Mar 31, 2026 | Shelton International Select Equity Fund | 1.3% | 1.3% | 4506.T, 4902.T, 6113.T, CHC.AX, DLG.MI, ERIC, GAMA.L, KLR.L, LYC.AX, VET.TO | AI, energy, Europe, geopolitics, infrastructure, international, Japan, small caps | VET.TO 6113.T LYC.AX |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Apis Deep Value Fund | Sumitomo Pharma | Health Care | Pharmaceuticals | Bear | Tokyo Stock Exchange | Acquisitions, Bear, Japan, Neuropsychiatric, Oncology, Patent cliff, pharmaceuticals, women's health | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||